Providers spent $44B on 340B drugs in 2021

The 30-year-old program that allows hospitals to buy drugs directly from manufacturers to avoid inflated prices, 340B, cost providers $43.9 billion in 2021, according to HHS’ Health Resources and Services Administration. 

Advertisement

Most of that spending — more than $34 billion — was from disproportionate share hospitals. Health center programs bought more than $2 billion worth of 340B drugs, children’s hospitals about $1.3 billion and critical access hospitals nearly $621 million.

“For 2021, discounted purchases under the 340B program reached a record $43.9 billion — an astonishing $5.9 billion (+15.6 percent) higher than its 2020 counterpart,” according to the Drug Channels Institute. 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.